ReviewBlood cancer journal2024

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.

Charlotte Pawlyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.